Literature DB >> 18474458

Immunohistochemical study before and after narrow band (311 nm) UVB treatment in vitiligo.

Vincenzo De Francesco1, Giuseppe Stinco, Sebastian Laspina, Maria Elena Parlangeli, Laura Mariuzzi, Pasquale Patrone.   

Abstract

The present study was aimed at evaluating correlations between clinical response and the histochemical and immunohistochemical changes in vitiligo patches treated with narrow-band UVB phototherapy. Eighteen patients, 13 females and 5 males, aged between 15 and 67 years, affected by vitiligo were recruited and 14 patients completed the study. Before starting the narrow-band UVB treatment three biopsies were carried out on the lesional, perilesional and healthy skin of each patient, excluding the face. After 9 months treatment an additional biopsy was performed on repigmented skin areas adjacent to the lesional biopsy site. For the histochemical evaluation, the Masson-Fontana argentaffin reaction was carried out; for the immunohistochemical study, two antigens were studied: tyrosinase and HMB 45. Clinical improvement was assessed by evaluating the repigmented surfaces, expressed in percentages of the respective vitiligo areas. The results obtained confirm the effectiveness and safety of narrow-band UVB phototherapy for vitiligo, in terms of both good clinical-histological results and absence of important side effects. In addition to attesting the efficacy of narrow-band UVB phototherapy, immunohistochemical tests also appeared to have a potential interest for prognostic purposes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18474458     DOI: 10.1684/ejd.2008.0391

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  1 in total

1.  Narrow band-ultraviolet B versus clobetasol propionate foam in the treatment of vitiligo: a retrospective study.

Authors:  Giuseppe Stinco; Giusto Trevisan; Cinzia Buligan; Giorgia Gregoraci; Sergio De Marchi; Nicola di Meo; Pasquale Patrone
Journal:  Dermatol Ther (Heidelb)       Date:  2013-06-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.